Clinical Trials in Guangzhou, Guandong
7 recruiting
Showing 1–6 of 6 trials
Recruiting
Phase 1Phase 2
Study of Lisaftoclax (APG-2575) Single Agent and Combination With Therapy in Patients Relapsed/Refractory AML
Myeloid MalignancyRelapsed/Refractory Acute Myeloid Leukaemia
Ascentage Pharma Group Inc.682 enrolled12 locationsNCT04501120
Recruiting
Phase 3
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
Psoriatic Arthritis
Takeda600 enrolled122 locationsNCT06671496
Recruiting
To Investigate REKOVELLE in Chinese Women Undergoing Assisted Reproductive Technologies: Effectiveness, Safety, and Patterns of Use in Real-world Practice
Infertility
Ferring Pharmaceuticals2,500 enrolled28 locationsNCT07029451
Recruiting
Phase 1Phase 2
Phase IIa Study for IPG11406 in Patients With Lupus Nephritis
Lupus Nephritis
Nanjing Immunophage Biotech Co., Ltd36 enrolled17 locationsNCT06717815
Recruiting
Phase 2
DZD8586 in Patients With Relapsed or Refractory CLL/SLL (TAI-SHAN8)
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Dizal Pharmaceuticals155 enrolled17 locationsNCT06539182
Recruiting
Phase 1
A Phase 1 Study of Gene-modified Autologous Hematopoietic Stem Cell (BD211) Treating β-thalassemia Major
Thalassemia
Shanghai BDgene Co., Ltd.9 enrolled3 locationsNCT06465550